Professional Documents
Culture Documents
The Role of Antioxidants in Protection From Impulse Noise
The Role of Antioxidants in Protection From Impulse Noise
The Role of Antioxidants in Protection From Impulse Noise
ABSTRACT: The hearing loss from exposure to noise and ototoxic drugs share
a number of audiological and pathological similarities. Recent research has
shown that reactive oxygen species (ROS) may be a common factor in both
noise- and drug-induced hearing loss. This review describes three experiments
that point to ROS as a causative factor in both noise- and drug-induced hearing
loss and antioxidants as a protective agent. In the first experiment, the ears of
chinchillas were treated with R-N6-phenylisopropyladenoisine (R-PIA) and exposed to 150-dB impulse noise. The treated ears developed substantially less
permanent hearing loss (PTS) and hair cell loss than the untreated ears. One
interpretation of this experiment is that R-PIA increases the availability of glutathione (GSH). In the second experiment, the role of GSH was specifically examined. The ears of chinchillas were treated with glutathione monoethylester
(GEE), a pro-GSH drug that has been shown to readily cross cell membranes
and increase GSH levels. The GEE-treated ears had significantly less PTS and
hair-cell loss than the nontreated ear. Previous research has shown that moderate levels of noise exposure can increase a subjects resistance to noise, and also
increase the availability of antioxidant enzymes in the cochlea. In the third experiment, chinchillas were given a series of toughening exposures (i.e., 6 h of
a 0.5-kHz OB noise at 95 dB for 10 days). After the series of toughening exposures, the subjects were treated with carboplatin, a drug that causes massive inner-hair-cell lesions in the chinchilla. The animals receiving the 10-day toughening exposure developed less PTS and hair-cell loss than the control animals.
INTRODUCTION
The pattern of hearing loss and cochlear pathology after exposure to traumatic
noise or ototoxic drugs such as aminoglycosides or cisplatin can be quite similar. In
fact, Hawkins8 has pointed out that it is impossible to identify the causative agent
from knowing either the audiogram or the pattern of hair cell loss. Twenty-five years
later, we are now learning that noise-induced and drug-induced hearing loss could
share a common damaging agent, specifically toxic free-oxygen radicals (FOR) and
other reactive oxygen species (ROS). The direct evidence for free-radical generation
and damage in the cochlea is sparse,2,16,29,30 but free-radical damage is a reasonable
hypothesis that is supported both by in vitro studies of FOR in cochlear cultures treata
To whom correspondence may be addressed. Phone: 716/829-2001; fax: 716/829-2980; email: donaldhe@acsu.buffalo.edu
368
369
ed with cisplatin18,24,25 and by indirect evidence showing the protective effects of antioxidant enzymes.7,11,26,27
High levels of noise are likely to create damaging free radicals by at least two
pathways. First, high levels of noise tax the mitochondrial respiratory process leading
to free-radical generation.14,23 Second, noise exposures lead to cochlea ischemia with
the consequence of the excitotoxic reaction at both the inner hair cell/VIII nerve
synapse22,28 and free radical generation at the surface of stria vascularis.29,30 Yamane
and colleagues exposed guinea pigs to high-level noise and assessed strial blood flow
and the presence of FOR, by using 3,3-diaminobenzidine to react with the O2 radical. When guinea pigs were sacrificed immediately after the exposure, there was a
sharp reduction in cochlear blood flow and a strong presence of O2 at the scala media surface of the stria. By 2 h after the exposure, there was evidence of cochlear
blood flow returning to normal, and most of the free radical activity subsided. The
Yamane study is provocative, but its scope is limited because it only measures O2
when the OH or ONOO radicals are potentially more toxic,4,5 and it focuses on the
medial wall of the stria vascularis and does not examine the presence of free radicals
in the organ of Corti.
370
to the other round window. The drug and saline were wicked off the round windows
after 30 min. One hour after the initial dose of R-PIA the chinchillas were exposed to
a 4-kHz octave band noise at 105 dB for 4 h. The R-PIA-treated ears recovered faster
and more completely (FIG. 1A), and had smaller hair cell lesions (FIG. 1B) than control ears. In a second complementary experiment, the same procedures were used, except the experimental treatment was buthionine-sulfoximine (BSO), a drug that
specifically inhibits GCS, the rate-limiting enzyme in the synthesis of GSH.10 There
were no differences between the ears treated with the small dose of BSO and the
saline-treated control ears immediately after the exposure. However, at 4 days postex-
(A)
(B)
FIGURE 1. (A) Evoked potential recovery curves following exposure to 4 kHz OBN. (B) Average (N = 8) OHC (top) and IHC (bottom) lesions.
371
posure, differences were apparent in three different measures obtained from separate
groups of animals: TS, GSH levels in the hair cells (assessed by mercury orange
staining of intracellular thiols), and specific activity levels of GCS. As shown in FIGURE 2, the difference in average TS between the ears ranged from approximately 5 dB
to nearly 20 dB. Presumably, TS differences were more pronounced at higher frequencies simply because the concentration of BSO was greater in the basal region of
the cochlea due to diffusion gradients from the round window. Data from histochemical staining of cochleas with mercury orange, and from biochemical analysis of
GCS activity in noise-exposed cochleas supported the physiological findings at 4
days postexposure. FIGURE 3 shows GCS activity levels determined at various times
after noise exposure in BSO- and saline-treated ears. The values shown are averages
determined from ears of three animals at each time point, and are expressed in units
per mg of protein. Separate analyses were performed for organ of Corti and stria vascularis fractions. At 4 days (96 h) postexposure, ears treated with BSO had lower
GCS levels than control ears in both stria and organ of Corti fractions. In the organ of
Corti fraction (FIG. 3, left panel), GCS level in the BSO-treated ears was 43% that in
the control ears. In the stria fraction (FIG. 3, right panel), GCS specific activity in the
BSO-treated ears was 61% that in the control ears. Mercury orange staining confirmed that GSH levels were reduced in BSO-treated ears relative to control ears.
OHCs of BSO-treated ears showed much less intense staining and more cell edema
and distortion of cell bodies than OHCs of control ears.
Despite the clear differences between BSO- and saline-treated ears at 4 days postexposure, there were no significant differences between ears in either PTS or hair cell
loss at 20 days postexposure. The lack of a permanent effect of BSO treatment in this
experiment is most likely due to the small dose of BSO used, and the short amount of
time it was allowed to penetrate into the cochlea. Nevertheless, the results show that
FIGURE 2. Average threshold shifts at 0, 4, and 20 days exposure for BSO and saline-treated
ears.
372
FIGURE 3. GCS concentration in stria and organ of Corti following noise exposure in BSO
and control ears.
treatment with a drug that inhibits GSH synthesis alters the pattern of recovery from
a traumatic noise exposure. The significant protection afforded by R-PIA and the altered pattern of recovery with BSO is consistent with the hypothesis that NIHL is
partially related to the action of toxic free radicals. The results raise the possibility of
reducing the degree of NIHL by either increasing the endogenous level of the antioxidant enzymes by certain prophylactic exposures or by direct drug intervention.
373
FIGURE 4. Scanning electron micrograph of chinchilla cochlea following exposure to 155dB impulses. Note cleft between pillar cells and OHC region.
experiment,15 a reasonable hypothesis is that the protection received by the toughened group is related to the increased presence of antioxidant enzymes.
Experiment I: Intervention with R-PIA
The first experiment was designed to test whether the presence of R-PIA renders
the ear more resistant to the mechanical damage associated with impulse noise. A
group of chinchillas (N = 6) were prepared for evoked potential recording by surgically implanting an electrode in the left and right inferior colliculus. Before exposure
to impulse noise, each chinchilla was anesthetized, both bullae were opened, and RPIA (103 M) was placed on the right round window membrane. Saline was placed on
the left round window in three animals, and nothing was done to the left ear of three
animals. Baseline audiograms were measured after the R-PIA was applied but before
the noise exposure. The animals were surgically repaired and allowed to recover for
several hours. When the animals were awake, they were exposed to 50 pairs of 150dB pSPL impulses. Hearing function was monitored after the exposure, and 20 days
later the animals were sacrificed and the cochleas were analyzed. As seen in FIGURE
6, the R-PIA-treated ears had less TTS immediately after the exposure and they recovered more completely. FIGURE 7 shows the R-PIA ear/control ear difference in
PTS at each frequency tested. The R-PIA-treated ears had less PTS at all frequencies.
The differences ranged from approximately 6 dB to 13 dB on average. The protection
against hair cell loss is seen in FIGURE 8. The R-PIA-treated ears have significantly
fewer missing IHCs (FIG. 8A) and OHCs (FIG. 8B).
The protection afforded by the R-PIA treatment may be due to several factors, as
R-PIA has multiple effects. It is an adenosine agonist; it is an inhibitor of glutamate
production; and it is a promoter of blood flow through the stimulation of nitric oxide
(NO) production.19 Each of these effects can influence the degree of hearing loss
374
FIGURE 5. Permanent threshold shifts for chinchillas exposed to either 150-dB impulses ()
or 10 days conditioning exposure and 150-dB impulses ().
caused by exposure to noise. For example, the activation of the adenosine receptor
can lead to an increase in GSH and a resultant decrease in FOR.2,6 High levels of
stimulation lead to glutamate excitotoxicity reaction/edema at the postsynaptic membrane of the VIII nerve. R-PIA partially suppresses glutamate synthesis. Finally, high
levels of noise exposure lead to cochlear ischemia.29,30 R-PIA may partially counteract the ischemia by the stimulation of NO that promotes local blood flow.21
Experiment II: Reduction of NIHL with GSH Monoethyl Ester
Each of the three mechanisms described earlier could possibly reduce the effects
of noise. A second experiment was designed to evaluate whether the protective effects were related to increased availability of GSH. Glutathione is synthesized in two
enzyme-catalyzed steps from glutamate, cysteine, and glycine:
-glutamylcysteine synthetase
and
-glutamyl-L-cysteine + ADP + Pi
glutathione synthetase
2. L--glutamyl-L-cysteine + glycine + ATP
375
FIGURE 6. Evoked potential recovery curves following exposure to 150-dB impulses in RPIA and control ears.
376
(A)
(B)
FIGURE 8. Cochleograms showing IHC (A) and OHC (B) losses for R-PIA treated and control ears.
teine synthtase. GCS normally functions at about 20% of its maximal activity, because it is feedback-inhibited by glutathione. GSH disappears rapidly from plasma
and is not readily transported across the cell membrane.1 Consequently, attempts to
upregulate endogenous levels of GSH directly are often ineffective. A more effective
way to increase GSH levels is to provide a derivative of glutathione that is easily
transported into cells, and the most promising of these is the monoethyl ester of GSH
(GSHEE). GSHEE is rapidly deesterified by intracellular estrase to GSH, and because
it does not involve the enzymes of glutathione it does not require the expenditure of
cellular energy. GSHEE is able to bypass the normal GSH pathway because it does not
involve glutathione synthesis and is not subject to GSH feedback inhibition, so that
intracellular levels can be elevated significantly.20
The chinchillas were assessed audiometrically prior to treatment. The animals
were anesthetized, and the right bulla was surgically opened to provide access to the
round-window membrane. Approximately 60 L of GSHEE was applied to the round
window, and the area was surgically closed approximately 15 min later. The animals
were exposed to 50 pairs of 150-dB pSPL impulse noise simulating gunfire bursts.
FIGURE 9 shows the permanent hearing loss (21 days postexposure) difference between treated and nontreated ears. The amount of PTS seen in the GSHEE-treated ears
was significantly less than the control ears. FIGURE 10 shows the difference in IHC
(FIG. 10A) and OHC (FIG. 10B) losses between the control and the GSHEE-treated
ears. The difference is quite dramatic, with the GSHEE-treated ears exhibiting almost
no damage, while the control ears show marked hair cell damage despite nearly normal thresholds. It must be remembered that the GSHEE experiment is a pilot project,
and based on only three animals, but the results, particularly the hair cell pathology,
are quite dramatic.
The first two experiments convincingly demonstrate that prior treatment with
GSH-promoting drugs (R-PIA and GSHEE) can dramatically reduce the effects of
noise. The results are strong, circumstantial evidence that antioxidant enzymes can
serve as a protective agent against NIHL.
377
FIGURE 9. Permanent threshold differences between GSHEE and control ears after exposure
to 150-dB impulses.
(A)
(B)
FIGURE 10. Cochleogram showing IHC losses for (A) GSHEE and (B) control ears.
378
exposures, it is interesting to see if the prophylactic effects of the conditioning exposure extend to protecting the ear from platinum-based ototoxic drugs.
Six chinchillas were made monaural and a recording electrode was permanently
placed in the inferior colliculus. Two weeks after the initial surgery the subjects
hearing thresholds were estimated using evoked potentials recorded from the awake
animal. The conditioning noise exposure was a series of exposures to 95-dB SPL 0.5
kHz OBN for 6 h/day for 10 days. This is the same conditioning paradigm that was
shown to be effective in reducing PTS and hair cell loss from impulse noise (see reference 9 and FIG. 5). The chinchillas daily hearing loss dropped between the first
and the fifth day of conditioning and then plateaued. After the last conditioning exposure, the animals were rested in quiet for 5 days and then were given carboplatin
(63 mg/kg IP) on two consecutive days.
The magnitude of the hearing loss 20 days after the exposure was minimal. As
shown in FIGURE 11, however, the animals who had the conditioning exposure before
the dose of carboplatin developed substantially less IHC as well as OHC loss, compared to nonexposed chinchillas given the same dose of carboplatin in a previous
study.12 Hofstetters animals12 had a mean IHC loss of 8090% throughout the
(A)
(B)
FIGURE 11. Cochleogram showing IHC (A) and OHC (B) for chinchilla given carboplatin or
a conditioning noise exposure and carboplatin.
379
cochlea and OHC losses averaging approximately 20%. In contrast, the six conditioned chinchillas had much less IHC loss in the apex than in the base, and average
OHC losses of less than 10%. It is important to note that the results are preliminary.
However, the initial findings provide support for the notion that a common etiological mechanism underlies damage caused by noise and by carboplatin. The likely
common feature leading to pathology is an increase in the free-radical population in
the cochlea, even though the source of the free radicals may be completely different.
For example, noise exposure is likely to lead to free-radical production by taxing the
mitochondrial system, by ischemia, or by rupturing cell membranes. The effects of
carboplatin are complicated. Studies with a related platinum-based anticancer compound, cisplatin, have shown that cisplatin treatment leads to an increase in superoxide dismutase (SOD), catalase, and malondialdehyde activity in the cochlea, but a
suppression of GSH, GSH-peroxidase, and GSH-reductase activity levels.24 Thus,
the critical factor may be the ratio between FOR/GSH and other antioxidants. The intervention with R-PIA or GSHEE may have a direct effect on this equation by simply
making more GSH available.
REFERENCES
1. ANDERSON, M. E., E. POWRIE, R. N. PURI & A. MEISTER. 1985. Glutathione monoethyl ester: preparation, uptake by tissues, and conversion to glutathione. Arch. Biochem. Biophys. 239(2): 538548.
2. BOBBIN, R. P., M. FALLON, C. LEBLANC & A. BABER. 1995. Evidence that glutathione is the
unidentified amine (Unk 2.5) released by high potassium into cochlear fluids. Hear. Res.
87: 4954.
3. CAMPO, P., M. SUBRAMANIAM & D. HENDERSON. 1991. Effects of conditioning exposures
on hearing loss from traumatic exposure. Hear. Res. 55: 195200.
4. CLERICI, W. J. & L. YANG. 1996. Direct effects of intraperilymphatic reactive oxygen
species generation on cochlear function. Hear. Res. 101(12): 1422.
5. CLERICI, W. J., D. L. DIMARTINO & M. R. PRASAD. 1995. Direct effects of reactive oxygen
species on cochlear outer hair cell shape in vitro. Hear. Res. 84: 3040.
6. FORD, M. S., S. B. MAGGIRWAR, L. P. RYBAK, C. WHITWORTH & V. RAMKUMAR. 1997. Expression and function of adenosine receptors in the chinchilla cochlea. Hear. Res. 105:
130140.
7. GARETZ, S. L., R. A. ALTSCHULER & J. SCHACT. 1994. Attenuation of gentamicin ototoxicity by glutathione in the guinea pig in vivo. Hear. Res. 77: 8187.
8. HAWKINS, J. E. 1973. Comparative otopathology: aging, noise and ototoxic drugs. Adv.
Oto-Rhino-Laryngol. 20: 125141.
9. HENSELMAN, L. W., D. HENDERSON, M. SUBRAMANIAM & V. SALLUSTIO. 1994. The effect of
conditioning exposures on hearing loss from impulse noise. Hear. Res. 78: 110.
10. HOFFMAN, D. W., C. A. WHITWORTH, K. L. JONES-KING & L. P. RYBAK. 1988. Potentiation
of ototoxicity by glutathione depletion. Ann. Otol. Rhinol. Laryngol. 97: 3641.
11. HOFFMAN, D. W., C. A. WHITWORTH, K. L. JONES & L. P. RYBAK. 1987. Nutritional status,
glutathione levels, and ototoxicity of loop diuretics and aminoglycoside antibiotics. Hear.
Res. 31(3): 217222.
12. HOFSTETTER, P., D. DING, N. POWERS & R. J. SALVI. 1997. Quantitative relationship of carboplatin dose to magnitude of inner and outer hair cell loss and the reduction in distortion product otoacoustic emission amplitude in chinchillas. Hear. Res. 112: 199215.
380
13. HU, B. H., X. Y. ZHENG, S. L. MCFADDEN, R. KOPKE & D. HENDERSON. 1997. R-PIA attenuates noise-induced hearing loss in the chinchilla. Hear. Res. 113: 198206.
14. HYDE, G. E. & E. W. RUBEL. 1995. Mitochondrial role in hair cell survival after injury.
Otolaryngol. Head Neck Surg. 113(5): 530540.
15. JACONO, A., B. HU, R. KOPKE, D. HENDERSON, T. VAN DE WATER & H. STEINMAN. 1998.
Changes in cochlear antioxidant enzyme activity levels after conditioning noise exposures in the chinchilla. Hear. Res.
16. KINOSHITA, T. & S. TOMIYAMA. 1994. Free radicals in inner ear immune responses: immunohistochemical study of myeloperoxidase. J. Oto-Rhino-Laryngol. Soc. Japan.
97(9): 16081612.
17. KOPKE, R. D. 1997. Use of organotypic cultures of Cortis organ to study the protective effects of antioxidant molecules on cisplatin-induced damage to auditory hair cells. Am. J.
Otol. 18: 559571.
18. LAUTERMANN, J., B. SONG, J. MCLAREN & J. SCHACHT. 1995. Diet is a risk factor in cisplatin ototoxicity. Hear. Res. 88(12): 4753.
19. MAGGIRWAR, S. B., D. DHANRAJ & S. M. SAMANI. 1994. Adenosine acts as endogenous activator of the cellular antioxidant defense system. Biochem. Biophys. Res. Commun.
201: 508515.
20. MEISTER, A., M. ANDERSON & O. HWANG. 1986. Intracellular cysteine and glutathione delivery systems. J. Am. Coll. Nutr. 5(2): 137151.
21. NATHAN, C. 1992. Nitric oxide as a secretory product of mammalian cells. FASEB 6:
30513069.
22. PUJOL, R., C. GERVAIS DALDIN, S. SAFFIEDINE, M. EYBALIN & J. L. PUEL. 1996. Repair of
inner hair cell-auditory nerve synapses and recovery of function after an excitotoxic injury. In Auditory System Plasticity and Regeneration, R. J. Salvi, D. Henderson, F. Fiorino, and V. Volletti, Eds.: 100107. Thieme Press. New York.
23. RADI, R., L. CASTRO, M. RODRIGUEZ, A. CASSINA & L. TOMSON. 1997. Free radical damage
to mitochondria. In Mitochondria and Free Radicals in Neurodegenerative Disease, M. F.
Beal, N. Howell, and I. Bodis-Wollner, Eds.: 5789. Wiley-Liss. New York.
24. RAVI, R., S. M. SOMANI & L. P. RYBAK. 1995. Mechanism of cisplatin ototoxicity: antioxidant system. Pharmacol. Toxicol. 76(6): 386394.
25. RYBAK, L. P., R. RAVI & S. M. SOMANI. 1995. Mechanism of protection by dethyldithiocarbamate against cisplatin ototoxicity: antioxidant system. Fundam. Appl. Toxicol. 26(2):
293300.
26. RYBAK, L. P., K. HUSAIN, L. EVENSON, C. MORRIS & C. WHITWORTH. 1997. Protection by 4methylthiobenzoic acid against cisplatin-induced ototoxicity: antioxidant system. Pharmacol. Toxicol. 81(4): 173179.
27. SEIDMAN, M. D., B. G. SHIVAPUJA & W. QUIRK. 1993. The protective effects of allopurinal
and superoxide dismutase on noise-induced cochlear damage. Otolaryngol. Head Neck
Surg. 106: 10521056.
28. SPOENDLIN, H. 1976. Anatomical changes following various noise exposures. In Effects of
Noise on Hearing, D. Henderson, R. P. Hamernik, D. Dosanjh and J. Mills, Eds.: 6490.
Raven Press. New York.
29. YAMANE, H., Y. NAKAI, M. TAKAYAMA, H. IGUCHI, T. NAKAGAWA & A. KOJIMA. 1995. Appearance of free radicals in the guinea pig inner ear after noise-induced acoustic trauma.
Eur. Arch. Oto-Rhino-Laryngol. 252(8): 504508.
30. YAMANE, H., Y. NAKAI, K. KONISHI, H. SAKAMOTO, Y. MATSUDA & H. IGUCHI. 1991. Strial
circulation impairment due to acoustic trauma. Acta Otolaryngology. 111: 8593.